Leading Manufacturer and Global Supplier of Mesalamine DelayedRelease 400MG Tablets

Taj Pharma India, headquartered in Vapi, Gujarat, stands out as one of the most trusted and top-ranked manufacturers, exporters, and suppliers of Mesalamine DelayedRelease 400MG Tablets. Recognized for its unwavering commitment to purity, therapeutic efficacy, and consistent quality, Taj Pharma has established its name in both domestic and international pharmaceutical markets, including Africa, the Middle East, and LATAM.


What is Mesalamine DelayedRelease 400MG Tablet?

Mesalamine DelayedRelease 400MG Tablets is a potent anti-inflammatory medication that belongs to the aminosalicylates drug class. It is extensively prescribed for the treatment and prevention of ulcerative colitis, a chronic inflammatory bowel disease (IBD) affecting the colon and rectum.

Mesalamine works by inhibiting the production of certain chemical substances that trigger inflammation in the bowel, thereby relieving symptoms such as stomach pain, diarrhea, rectal bleeding, and discomfort. This medicine is not a cure, but it helps manage the condition effectively and prevents future flare-ups.


Why Choose Taj Pharma for Mesalamine Delayed Release 400MG Tablets?

✔ WHO-GMP Certified Manufacturing Facilities

Taj Pharma operates state-of-the-art pharmaceutical plants compliant with WHO-GMP, EU-GMP, and ISO 9001:2015 quality standards. Each batch of Mesalamine Delayed Release 400MG Tablets undergoes rigorous quality control processes to ensure purity, stability, and bioavailability.

✔ Global Reach with PAN India Supply Chain

From Mumbai to Maharashtra, and across PAN India, Taj Pharma guarantees timely delivery and seamless logistics management. The company is also a preferred exporter for Mesalamine Delayed Release Tablets in Africa, the Middle East, South-East Asia, and LATAM regions.

✔ Affordable Pricing & PCD Pharma Franchise Opportunities

Taj Pharma is also offering Mesalamine DelayedRelease 400MG Tablets under PCD Pharma Franchise partnerships across India, helping entrepreneurs and pharma distributors grow with reliable, high-quality products at competitive pricing.


Product Highlights – Mesalamine DelayedRelease 400MG Tablets

  • Brand Name: Available in various proprietary and generic names
  • Dosage Form: DelayedRelease Tablets
  • Strength: 400MG
  • Packaging: Customized blister packs or strip packs
  • Therapeutic Class: Gastroenterology
  • Usage: Anti-inflammatory treatment for Ulcerative Colitis
  • Shelf Life: 24 to 36 months depending on the region-specific regulatory approvals

Mechanism of Action

Mesalamine works locally in the colon to inhibit cyclooxygenase and lipoxygenase pathways, effectively reducing pro-inflammatory prostaglandins and leukotrienes. It acts specifically in the distal ileum and colon, making it an ideal drug for treating inflammatory bowel diseases.


Indications and Usage

  • Treatment of mild to moderately active ulcerative colitis
  • Maintenance of remission in ulcerative colitis
  • Helps reduce rectal bleeding, mucus discharge, and abdominal cramps

Dosage and Administration

  • Typically prescribed 400MG three to four times daily, or as directed by a healthcare provider.
  • Tablets should be swallowed whole, not chewed or crushed, to maintain the delayed-release formulation.
  • Recommended to be taken with meals to reduce gastrointestinal side effects.

Side Effects of Mesalamine DelayedRelease 400MG Tablets

Like all medications, Mesalamine may cause side effects. Most are mild and manageable, but some may require medical attention.

Common Side Effects:

  • Nausea
  • Diarrhea
  • Flatulence
  • Stomach discomfort
  • Headache
  • Itching or rash

Serious but Rare Side Effects:

  • Severe allergic reactions (swelling of lips, face, tongue)
  • Bruising or unusual bleeding
  • High fever, sore throat
  • Fatigue or excessive tiredness

Patients experiencing any severe adverse effects must contact a healthcare provider immediately.


Contraindications & Precautions

  • Not recommended for individuals with a known hypersensitivity to salicylates or mesalamine.
  • Use during pregnancy should be evaluated by a doctor.
  • Breastfeeding mothers should exercise caution as mesalamine may pass into breastmilk and potentially harm the infant.
  • Patients with renal or hepatic impairment should use this medication only under strict medical supervision.

Mesalamine Delayed Release 400MG Tablets – PAN India Manufacturer and Global Exporter

Taj Pharma is not only a leading Mesalamine manufacturer in India, but also an international exporter, shipping bulk consignments to:

  • African Markets: Nigeria, Kenya, Ghana, South Africa
  • Middle East: UAE, Saudi Arabia, Iraq, Oman
  • Latin America: Brazil, Colombia, Peru, Mexico
  • CIS & Eastern Europe: Ukraine, Kazakhstan, Belarus

With a robust regulatory and documentation support system, Taj Pharma ensures swift product registrations and hassle-free customs clearance, making it a top-choice supplier for governments, NGOs, hospitals, and private labeling partners.


PCD Pharma Franchise for Mesalamine DelayedRelease 400MG Tablets

Taj Pharma extends a lucrative opportunity through its PCD Pharma Franchise model. Entrepreneurs and distributors can collaborate with us to market high-quality gastroenterology products, including Mesalamine DelayedRelease 400MG Tablets, under their own brand or ours.

Advantages:

  • Monopoly rights
  • Promotional inputs
  • Regular product updates
  • Assured product availability
  • Affordable pricing and higher profit margins

Why Mesalamine Delayed Release 400MG Tablets are Preferred?

  • Proven efficacy in treating and preventing ulcerative colitis
  • Fewer systemic side effects due to targeted action in the colon
  • Well-tolerated in both adult and pediatric populations
  • Suitable for long-term maintenance therapy

Trusted by Healthcare Providers Worldwide

Doctors and gastroenterologists across the globe prefer Taj Pharma’s Mesalamine Delayed Release 400MG Tablets due to:

  • Unwavering commitment to quality
  • Transparent clinical documentation
  • GMP-approved manufacturing protocols
  • Continuous post-market pharmacovigilance tracking

Conclusion

Taj Pharma India is a pioneer and a dependable name in the global pharmaceutical landscape, especially in the field of gastroenterology medicines. Our Mesalamine DelayedRelease 400MG Tablets reflect our vision of delivering affordable, safe, and effective healthcare solutions to patients around the world. Whether you’re a buyer, distributor, or healthcare provider, Taj Pharma ensures a partnership that is built on quality, compliance, and trust.


For inquiries or bulk orders of Mesalamine Delayed Release 400MG Tablets, reach out to us at:

Taj Pharma India
Vapi, Gujarat, India
📧 [Email Us]
🌐 www.tajpharma.com